GSK PLC (GSK)
40.90
+0.04
(+0.09%)
USD |
NYSE |
Apr 25, 16:00
40.90
0.00 (0.00%)
After-Hours: 20:00
GSK Income from Discontinued Operations (Quarterly)
Income from Discontinued Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Income from Discontinued Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -- |
September 30, 2023 | -- |
June 30, 2023 | -- |
March 31, 2023 | -- |
December 31, 2022 | -- |
September 30, 2022 | -- |
Date | Value |
---|---|
June 30, 2022 | -- |
March 31, 2022 | -- |
December 31, 2021 | -- |
September 30, 2021 | -- |
June 30, 2021 | -- |
Income from Discontinued Operations Definition
Income from operations that used to be a part of the business but are not any longer. This could be due to the sale of a portion of a business, shutting down a division, or something else.
Income from Discontinued Operations (Quarterly) Range, Past 5 Years
Income from Discontinued Operations (Quarterly) Benchmarks
AstraZeneca PLC | -- |
Haleon PLC | -- |
Novo Nordisk A/S | -- |
Pfizer Inc | Upgrade |
Sanofi SA | -- |